EH Mole, are you still out there?













When the moon is in the seventh house and the swallows come home to capistrano, look over your shoulder and you will see it all unfold. Or something like that.

Are you serious? Asking a question like that on CP?
 






Finishing the projections of losartan intrusion.
Soon to have 90 day trends 2011
Insurance offering lucrative incentives for pharmacies
to switch patients.
The losses to ARB's are pretty severe. There were no
contingencys for the OT loss. Braintrust didn't believe
it could swing that way. What else is new.
Early summer is unlikely other than some minor tweeks.
Ratings will be abysmal. They do not want reps with 3's
regardless of performance.
Bonus will dwindle, Fanapt Aliskren are toast.
Cost benefit analysis shows diovan gleevec retention is
not impacted greatly by reps , sorry.
They will make sure reps are miserable take that to the bank
Late summer early fall have those resumes updated
MD's DM's will be taking care of their cronies so beware
of dubious FCR & Ratings
 






When the moon is in the seventh house and the swallows come home to capistrano, look over your shoulder and you will see it all unfold. Or something like that.

Are you serious? Asking a question like that on CP?

Dude, how is that question so much different than the 8 million others asked on CP? Mole usually knows his/her stuff.